INCYTE CORPORATION Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase
INCYTE CORPORATION (INCY) had Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase of 2.00% as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease · last filed 2026-02-10
- 2025-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 2.00%.
- 2024-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 2.25%.
- 2023-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 2.25%.
- 2022-12-31: Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase 2.25%.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase |
|---|---|
| 2025-12-31 | 2.00% 10-K · filed 2026-02-10 |
| 2024-12-31 | 2.25% 10-K · filed 2026-02-10 |
| 2023-12-31 | 2.25% 10-K · filed 2025-02-10 |
| 2022-12-31 | 2.25% 10-K · filed 2024-02-13 |
| 2021-12-31 | 2.00% 10-K · filed 2023-02-07 |
| 2020-12-31 | 2.00% 10-K · filed 2022-02-08 |
| 2019-12-31 | 2.25% 10-K · filed 2021-02-09 |
| 2018-12-31 | 2.25% 10-K · filed 2020-02-13 |
| 2017-12-31 | 2.00% 10-K · filed 2019-02-14 |
| 2016-12-31 | 1.50% 10-K · filed 2018-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |